Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price dropped 0.9% on Wednesday . The company traded as low as $1.67 and last traded at $1.69. Approximately 4,531,783 shares traded hands during trading, a decline of 82% from the average daily volume of 25,203,791 shares. The stock had previously closed at $1.70.
Tilray Price Performance
The company has a market capitalization of $1.45 billion, a P/E ratio of -3.83 and a beta of 2.13. The stock’s fifty day simple moving average is $1.82 and its 200-day simple moving average is $1.87. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The business had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. Tilray’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.15) EPS. On average, equities analysts forecast that Tilray Inc will post -0.12 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Tilray
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
- Five stocks we like better than Tilray
- How to Calculate Return on Investment (ROI)
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- How to invest in marijuana stocks in 7 steps
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- What Are Trending Stocks? Trending Stocks Explained
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.